Rresearchers at the Blanchette Rockefeller Neurosciences Institute (BRNI) announced findings from a new study that offer significant promise for a new therapeutic and diagnostic approach to Alzheimer's disease (AD) that has remained so refractory to effective and early drug treatment.
I am writing this letter in reference to the recent paper by Danton and Catalano .
Decline in daily functioning associated with Alzheimer’s disease is related to alterations in activity in certain regions of the brain, according to a study published in the August 2014 issue of the Journal of Alzheimer’s Disease.
In a long-term, large-scale population-based study of individuals aged 55 years or older in the general population researchers found that those diagnosed with mild cognitive impairment (MCI) had a four-fold increased risk of developing dementia or Alzheimer’s disease (AD) compared to cognitively healthy individuals.
JAD Is Ranked as the Most Productive Journal and Mark Smith and George Perry Recognized as the Top Two Authors in the AD Research
New research led by Drexel University College of Medicine suggests that Alzheimer’s disease (AD) and vascular dementia (VaD) have much more in common than diagnostic guidelines currently allow.
No front page content has been created yet.